390 related articles for article (PubMed ID: 27807637)
1. Clinical performance of antibodies to prothrombin and thrombin in Chinese patients with antiphospholipid syndrome: potential interest in discriminating patients with thrombotic events and non-thrombotic events.
Zhang S; Wu Z; Li J; Li P; Chen S; Wen X; Li L; Zhang W; Zhao J; Zhang F; Li Y
Rheumatol Int; 2017 Apr; 37(4):579-584. PubMed ID: 27807637
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to phosphatidylserine/prothrombin (aPS/PT) enhanced the diagnostic performance in Chinese patients with antiphospholipid syndrome.
Zhang S; Wu Z; Zhang W; Zhao J; Norman GL; Zeng X; Zhang F; Li Y
Clin Chem Lab Med; 2018 May; 56(6):939-946. PubMed ID: 29561729
[TBL] [Abstract][Full Text] [Related]
3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the clinical relevance of anti-annexin-A5 antibodies in Chinese patients with antiphospholipid syndrome.
Zhang S; Wu Z; Li J; Wen X; Li L; Zhang W; Zhao J; Zhang F; Li Y
Clin Rheumatol; 2017 Feb; 36(2):407-412. PubMed ID: 28000012
[TBL] [Abstract][Full Text] [Related]
5. Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review.
Sciascia S; Sanna G; Murru V; Roccatello D; Khamashta MA; Bertolaccini ML
Thromb Haemost; 2014 Feb; 111(2):354-64. PubMed ID: 24172938
[TBL] [Abstract][Full Text] [Related]
6. Antiphosphatidylserine/prothrombin antibodies in primary antiphospholipid syndrome.
Hoxha A; Ruffatti A; Tonello M; Bontadi A; Salvan E; Banzato A; Pengo V; Punzi L
Lupus; 2012 Jun; 21(7):787-9. PubMed ID: 22635234
[TBL] [Abstract][Full Text] [Related]
7. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome.
Shi H; Zheng H; Yin YF; Hu QY; Teng JL; Sun Y; Liu HL; Cheng XB; Ye JN; Su YT; Wu XY; Zhou JF; Norman GL; Gong HY; Shi XM; Peng YB; Wang XF; Yang CD
Clin Chem Lab Med; 2018 Mar; 56(4):614-624. PubMed ID: 29166262
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of autoantibodies directed against prothrombin in primary antiphospholipid syndrome.
Hoxha A; Ruffatti A; Pittoni M; Bontadi A; Tonello M; Salvan E; Plebani M; Punzi L
Clin Chim Acta; 2012 May; 413(9-10):911-3. PubMed ID: 22349599
[TBL] [Abstract][Full Text] [Related]
9. Antiphosphatidylserine/prothrombin (aPS/PT) antibodies are associated with Raynaud phenomenon and migraine in primary thrombotic antiphospholipid syndrome.
Kopytek M; Natorska J; Undas A
Lupus; 2018 Apr; 27(5):812-819. PubMed ID: 29338587
[TBL] [Abstract][Full Text] [Related]
10. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
Miesbach W; Matthias T; Scharrer I
Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies against phosphatidylserine, prothrombin and phosphatidylserine-prothrombin complex: identical or distinct diagnostic tools for antiphospholipid syndrome?
Jaskowski TD; Wilson AR; Hill HR; Branch WD; Tebo AE
Clin Chim Acta; 2009 Dec; 410(1-2):19-24. PubMed ID: 19751711
[TBL] [Abstract][Full Text] [Related]
12. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
Atsumi T; Ieko M; Bertolaccini ML; Ichikawa K; Tsutsumi A; Matsuura E; Koike T
Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients.
Zhu L; Li C; Liu N; Yang X; Jia RL; Mu R; Su Y; Li ZG
Clin Rheumatol; 2017 Feb; 36(2):401-406. PubMed ID: 28050648
[TBL] [Abstract][Full Text] [Related]
14. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of antibodies to prothrombin in solid phase (aPT) and to phosphatidylserine-prothrombin complex (aPS/PT) in patients with and without lupus anticoagulant.
Bertolaccini ML; Sciascia S; Murru V; Garcia-Fernandez C; Sanna G; Khamashta MA
Thromb Haemost; 2013 Feb; 109(2):207-13. PubMed ID: 23254928
[TBL] [Abstract][Full Text] [Related]
16. Antiphosphatidylserine/prothrombin antibodies as biomarkers to identify severe primary antiphospholipid syndrome.
Hoxha A; Mattia E; Tonello M; Grava C; Pengo V; Ruffatti A
Clin Chem Lab Med; 2017 May; 55(6):890-898. PubMed ID: 27816952
[TBL] [Abstract][Full Text] [Related]
17. Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential markers of antiphospholipid syndrome.
Vlagea A; Gil A; Cuesta MV; Arribas F; Diez J; Lavilla P; Pascual-Salcedo D
Clin Appl Thromb Hemost; 2013 Jun; 19(3):289-96. PubMed ID: 22387581
[TBL] [Abstract][Full Text] [Related]
18. Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Koike T; Hughes GR; Khamashta MA
Thromb Haemost; 2005 Feb; 93(2):289-97. PubMed ID: 15711745
[TBL] [Abstract][Full Text] [Related]
19. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
Hoxha A; Ruffatti A; Mattia E; Meneghel L; Tonello M; Salvan E; Pengo V; Punzi L
Clin Chem Lab Med; 2015 Jul; 53(8):1265-70. PubMed ID: 25562605
[TBL] [Abstract][Full Text] [Related]
20. Interest of IgG and IgM antiprothrombin autoantibodies in the exploration of antiphospholipid syndrome: a 5-year retrospective study.
Bertin D; Beziane A; Resseguier N; Pelissier M; Morange PE; Mege JL; Bardin N
Rheumatology (Oxford); 2020 Jul; 59(7):1539-1544. PubMed ID: 31630203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
